Sinovac Biotech's total assets for Q1 2024 were $13.66B, a decrease of -0.49% from the previous quarter. SVA total liabilities were $1.64B for the fiscal quarter, a 9.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.